Pictor Labs, Inc. reported raising $7.61 Million in an initial SEC Form D filing, from an offering of $15.2 Million
PRIVATEMay 27, 2022$7.6M of $15.2M raised
Amount Raised
$7.61 Million
$7.61 Million sold, per SEC Form D (first sale May 27, 2022)
Round Type
Venture
Los AngelesOtherInformation TechnologyBiotechnologySoftwareHealth CareArtificial Intelligence
Quick answer
Pictor Labs raised $7.61 Million in a funding round, dated May 27, 2022. Pictor Labs is based in Los Angeles, California, United States.
How much did Pictor Labs raise?
Pictor Labs raised $7.61 Million in a funding round on May 27, 2022.
What does Pictor Labs do?
PictorLabs, Inc. is a digital pathology company developing an AI-powered virtual staining platform to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes.
Where is Pictor Labs based and how big is it?
Pictor Labs is based in Los Angeles, California, United States.
Who are the decision-makers at Pictor Labs?
Fundz holds 3 contacts at Pictor Labs, including the Executive Chair. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Pictor Labs, and when
A new round usually means Pictor Labs is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Pictor Labs raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Pictor Labs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pictor Labs. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Pictor Labs
Location
Los Angeles, California, United States
About
PictorLabs, Inc. is a digital pathology company developing an AI-powered virtual staining platform to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes. Led by a team with deep expertise in bioengineering, artificial intelligence, and health-tech product development, the Company is reimagining existing histopathology workflows, accelerating clinical and diagnostic results, and improving process sustainability. From a single unstained tissue sample, PictorLabs’ proprietary platform can produce an unlimited number of virtual stains that are indistinguishable from analogous chemical stains. PictorLabs is developing products that replicate standard of care stains and is creating specialized virtual biomarker stains for indications in which there is a large demand for novel and accelerated diagnostic tests.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pictor Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.